363 related articles for article (PubMed ID: 27661107)
41. Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells.
Neumeyer V; Grandl M; Dietl A; Brutau-Abia A; Allgäuer M; Kalali B; Zhang Y; Pan KF; Steiger K; Vieth M; Anton M; Mejías-Luque R; Gerhard M
Carcinogenesis; 2019 Jun; 40(4):551-559. PubMed ID: 30380024
[TBL] [Abstract][Full Text] [Related]
42. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
[TBL] [Abstract][Full Text] [Related]
43. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.
Hao HX; Xie Y; Zhang Y; Charlat O; Oster E; Avello M; Lei H; Mickanin C; Liu D; Ruffner H; Mao X; Ma Q; Zamponi R; Bouwmeester T; Finan PM; Kirschner MW; Porter JA; Serluca FC; Cong F
Nature; 2012 Apr; 485(7397):195-200. PubMed ID: 22575959
[TBL] [Abstract][Full Text] [Related]
44. RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF
Elez E; Ros J; Fernández J; Villacampa G; Moreno-Cárdenas AB; Arenillas C; Bernatowicz K; Comas R; Li S; Kodack DP; Fasani R; Garcia A; Gonzalo-Ruiz J; Piris-Gimenez A; Nuciforo P; Kerr G; Intini R; Montagna A; Germani MM; Randon G; Vivancos A; Smits R; Graus D; Perez-Lopez R; Cremolini C; Lonardi S; Pietrantonio F; Dienstmann R; Tabernero J; Toledo RA
Nat Med; 2022 Oct; 28(10):2162-2170. PubMed ID: 36097219
[TBL] [Abstract][Full Text] [Related]
45. RNF43 interacts with NEDL1 and regulates p53-mediated transcription.
Shinada K; Tsukiyama T; Sho T; Okumura F; Asaka M; Hatakeyama S
Biochem Biophys Res Commun; 2011 Jan; 404(1):143-7. PubMed ID: 21108931
[TBL] [Abstract][Full Text] [Related]
46. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
[TBL] [Abstract][Full Text] [Related]
47. Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers.
Bond CE; Umapathy A; Buttenshaw RL; Wockner L; Leggett BA; Whitehall VL
PLoS One; 2012; 7(10):e47483. PubMed ID: 23110075
[TBL] [Abstract][Full Text] [Related]
48. WNT Pathway Gene Mutations Are Associated With the Presence of Dysplasia in Colorectal Sessile Serrated Adenoma/Polyps.
Hashimoto T; Yamashita S; Yoshida H; Taniguchi H; Ushijima T; Yamada T; Saito Y; Ochiai A; Sekine S; Hiraoka N
Am J Surg Pathol; 2017 Sep; 41(9):1188-1197. PubMed ID: 28614199
[TBL] [Abstract][Full Text] [Related]
49. Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin.
Zebisch M; Xu Y; Krastev C; MacDonald BT; Chen M; Gilbert RJ; He X; Jones EY
Nat Commun; 2013; 4():2787. PubMed ID: 24225776
[TBL] [Abstract][Full Text] [Related]
50. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.
Nakaji Y; Oki E; Nakanishi R; Ando K; Sugiyama M; Nakashima Y; Yamashita N; Saeki H; Oda Y; Maehara Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042
[TBL] [Abstract][Full Text] [Related]
52. SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis.
Tong K; Kothari OA; Haro KS; Panda A; Bandari MM; Carrick JN; Hur JJ; Zhang L; Chan CS; Xing J; Gatza ML; Ganesan S; Verzi MP
Oncogene; 2021 Oct; 40(41):6034-6048. PubMed ID: 34453124
[TBL] [Abstract][Full Text] [Related]
53. Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer.
Maestro ML; Vidaurreta M; Sanz-Casla MT; Rafael S; Veganzones S; Martínez A; Aguilera C; Herranz MD; Cerdán J; Arroyo M
Ann Surg Oncol; 2007 Mar; 14(3):1229-36. PubMed ID: 17195912
[TBL] [Abstract][Full Text] [Related]
54. Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway.
Nosho K; Igarashi H; Nojima M; Ito M; Maruyama R; Yoshii S; Naito T; Sukawa Y; Mikami M; Sumioka W; Yamamoto E; Kurokawa S; Adachi Y; Takahashi H; Okuda H; Kusumi T; Hosokawa M; Fujita M; Hasegawa T; Okita K; Hirata K; Suzuki H; Yamamoto H; Shinomura Y
Carcinogenesis; 2014 Apr; 35(4):776-83. PubMed ID: 24242331
[TBL] [Abstract][Full Text] [Related]
55. Structures of Wnt-antagonist ZNRF3 and its complex with R-spondin 1 and implications for signaling.
Peng WC; de Lau W; Madoori PK; Forneris F; Granneman JC; Clevers H; Gros P
PLoS One; 2013; 8(12):e83110. PubMed ID: 24349440
[TBL] [Abstract][Full Text] [Related]
56. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status.
Jang MH; Kim S; Hwang DY; Kim WY; Lim SD; Kim WS; Hwang TS; Han HS
J Korean Med Sci; 2017 Jan; 32(1):38-46. PubMed ID: 27914130
[TBL] [Abstract][Full Text] [Related]
57. Microsatellite stable colorectal cancers stratified by the BRAF V600E mutation show distinct patterns of chromosomal instability.
Bond CE; Nancarrow DJ; Wockner LF; Wallace L; Montgomery GW; Leggett BA; Whitehall VL
PLoS One; 2014; 9(3):e91739. PubMed ID: 24651849
[TBL] [Abstract][Full Text] [Related]
58. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis.
Bossard C; Denis MG; Bézieau S; Bach-Ngohou K; Bourreille A; Laboisse CL; Mosnier JF
Oncol Rep; 2007 Nov; 18(5):1093-7. PubMed ID: 17914558
[TBL] [Abstract][Full Text] [Related]
59. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
[TBL] [Abstract][Full Text] [Related]
60. Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.
Li S; Lavrijsen M; Bakker A; Magierowski M; Magierowska K; Liu P; Wang W; Peppelenbosch MP; Smits R
Oncogene; 2020 Apr; 39(17):3458-3472. PubMed ID: 32103169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
